BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market - bioinformant.com/biolife-solu... @qkine.bsky.social @qkinebio.bsky.social

TriHaz Solutions Opens New Chattanooga, Tennessee Facility to Expand Regulated Medical Waste Services Across the Southeast - bioinformant.com/trihaz-solut...

FDA Grants RMAT to iRegene’s NouvNeu001, Making It World’s First iPSC Therapy with FTD and RMAT Recognitions - bioinformant.com/fda-grants-r...

Nucleus Biologics Launches Krakatoa® K500: A Pod-Based, On-Demand Media and Buffer Manufacturing System Transforming Scale Bioproduction - bioinformant.com/nucleus-biol...

I Peace Announces Successful Generation of Human iPS Cells from NKT Cells and Commences Their Availability - bioinformant.com/i-peace-anno...

Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience - bioinformant.com/lineage-part... @lineagecell.bsky.social

Cytora, Made Scientific, and Zeo ScientifiX Partner to Manufacture and Commercialize Cytora’s Allogeneic Stem Cell Therapy in U.S. - bioinformant.com/cytora-thera...

Top iPSC Providers Transforming Preclinical Safety for Big Pharma - bioinformant.com/ipsc-derived... @axolbio.bsky.social @reprocell.bsky.social @insphero.bsky.social

Novo Nordisk Foundation Commits DKK 5.5 Billion to the BioInnovation Institute (BII) through 2035 - bioinformant.com/novo-nordisk... @novonordisk.bsky.social

Learn how to unlock the link between EV content and function in MSC research. Join RoosterBio Inc. for an insightful webinar, EV Content vs Function: Using Analytical Tools to Reveal the Connection, on Tuesday, February 10th at 11:00 AM ET. us02web.zoom.us/webinar/regi...

Qkine Limited and Akron Bio Announce Strategic Partnership - bioinformant.com/qkine-and-ak... Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics @qkinebio.bsky.social

CHU Toulouse and Cell-Easy Launch A-MUSE, a Phase 1/2 Clinical Trial Evaluating the CellReady® Allogeneic MSC Platform in Systemic Sclerosis - bioinformant.com/chu-toulouse...

FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia - bioinformant.com/fda-approves...

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies - bioinformant.com/cellistic-ne...

We continue to be awed by RoosterBio’s leadership in cell culture innovation and the way they simplify processes while enabling scalability: Generate Billions of Xeno-Free Fibroblasts for Your R&D Program: www.roosterbio.com/products/xen...

WORD+2026 Connecting Global NAM Research. #Bettertogether Organoids, Organ-on-a-Chip, Assembloids and innovative NAMS - bioinformant.com/word2026/ In just three weeks time, the 5th WORD+ event brings together leading researchers, societies and technologies in Cambridge, U.K.

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered “virtual hearts” - bioinformant.com/the-jackson-... @jacksonlab.bsky.social

Kobe University Introduces a Simplified Cryopreservation Method for iPSCs - bioinformant.com/kobe-univers...

Big Pharma Makes M&A Moves to Secure Positions in In Vivo Cell Engineering - bioinformant.com/big-pharma-c... @bristolmyerssquibb.bsky.social @astra-zeneca.bsky.social

TheWell Bioscience and PeptiGrowth Enter into Marketing Collaboration Agreement to Advance Next-Generation Cell Culture Solutions - bioinformant.com/thewell-bios...

10 Cell Therapy Stocks That Will Be Intriguing to Watch in 2026 - bioinformant.com/cell-therapy... @vistagen.bsky.social

GMP Manufacturing of iPSC Master Cell Banks for Allogeneic Therapies at REPROCELL: A Cost-Optimized Approach - bioinformant.com/gmp-manufact... @reprocell.bsky.social

Congratulations to the PeptiGrowth Inc. team on the launch of its IL-15 alternative peptide, an exciting advance in synthetic growth factor technology. PeptiGrowth Inc. is Launching a Novel Synthetic Peptide: IL-15 alternative peptide: bioinformant.com/peptigrowth-...

Novo Withdraws from $598M Heartseed Partnership; Pursues Short-Term Profit Over iPSC Potential - bioinformant.com/novo-withdra... @novonordisk.bsky.social

Curi Bio Secures $10M Series B to Scale Human-Relevant iPSC-Based Preclinical Platforms and Advanced Data Analysis for Drug Discovery - bioinformant.com/curi-bio-sec... @curibio.bsky.social

What has 2025 taught us about stem cell innovation and market dynamics? - bioinformant.com/stem-cell-in...

BMS Makes a Bold Leap into CAR-T Buying Orbital Therapeutics for $1.5B - bioinformant.com/bms-makes-a-... @bristolmyerssquibb.bsky.social

A Spark Becomes a Surge: How Ryoncil Reignited MSC Development - bioinformant.com/yoncil-reign...

Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank - bioinformant.com/who-is-cryoh...

A Complete Guide to Induced Pluripotent Stem Cell (iPSC) Core Facilities - bioinformant.com/ipsc-core-fa... @cornelluniversity.bsky.social @harvard.edu @mit.edu @scicambridge.bsky.social @salkinstitute.bsky.social

The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy - bioinformant.com/stem-cell-th...

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting #Exosome Drug Delivery Platform - bioinformant.com/esco-aster-s...

GMP Manufacturing of iPSC Master Cell Banks for Allogeneic Therapies at REPROCELL: A Cost-Optimized Approach REPROCELL functions as a true one-stop stem cell biotech, unifying the entire #iPSC value chain under a single, dependable partner. bioinformant.com/gmp-manufact... @reprocell.bsky.social

Big Pharma Makes M&A Moves to Secure Positions in In Vivo Cell Engineering - bioinformant.com/big-pharma-c... @abbvie.bsky.social @bristolmyerssquibb.bsky.social @astra-zeneca.bsky.social

AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer - bioinformant.com/aabb-certifi... @aabbupdates.bsky.social

GMP Manufacturing of iPSC Master Cell Banks for Allogeneic Therapies at REPROCELL: A Cost-Optimized Approach REPROCELL functions as a true one-stop stem cell biotech, unifying the entire #iPSC value chain under a single, dependable partner. bioinformant.com/gmp-manufact... @reprocell.bsky.social

Cell Therapy Industry News Round-Up: November 2, 2025 - bioinformant.com/cell-therapy... @cirmnews.bsky.social @slingshotbio.bsky.social

What is CAR-T Cell Therapy? A New Way to Treat Cancer - bioinformant.com/car-t-cell-t... @novartis.bsky.social @bristolmyerssquibb.bsky.social

Vector BioMed Expands LENTIVERSE™ Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access - bioinformant.com/vector-biome...

Bridging the Gap: Streamlining iPSC-Derived Cell Line Development from Donor Cells to MCB - bioinformant.com/ipsc-derived...

Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology - bioinformant.com/applied-stem... @appliedstemcell.bsky.social

🔬GMP-ready iPSC line development starts on day one. Many teams use R&D workflows early, then face major gaps at GMP, from non-compliant reagents to missing documentation. Learn how to avoid these pitfalls in Cellistic's Nov 19 webinar at 11am EST: Register here: www.cellistic.com/insights/web...

Global Database of Cultured (“Clean”) Meat Companies, 2025 - bioinformant.com/product/cult...

iOrganBio Emerges from Stealth with $2M and Launches CellForge™, the First AI-Powered Cell Manufacturing Platform - bioinformant.com/iorganbio-em...

The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - bioinformant.com/ipsc-derived... @aspenneuroscience.bsky.social @greenstonebio.bsky.social @novonordisk.bsky.social @reprocell.bsky.social @riken-brc-en.bsky.social

The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - bioinformant.com/cellistic-st...

RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01 - bioinformant.com/roosterbio-a...

BBG Advanced Therapies collects first cell donation on one-of-a-kind bus - bioinformant.com/bbg-advanced... The world’s only mobile leukapheresis center recorded its first donation on Monday, Oct. 20, marking the beginning of a new era for global healthcare.

Big Pharma Makes M&A Moves to Secure Positions in In Vivo Cell Engineering - bioinformant.com/big-pharma-c...

CIRM’s iPSC Repository Closes, Marking the End of a Landmark Resource for Stem Cell Research - bioinformant.com/cirms-ipsc-r... @cirmnews.bsky.social